Faculty & Research

The PTEN Research Institute brings together a global faculty of scientists and clinicians dedicated to advancing the understanding of PTEN biology and related cancer susceptibility syndromes. Our mission is to translate cutting-edge scientific discoveries into innovative therapies that improve cancer prevention, diagnosis, and treatment. Through collaborations with leading academic institutions and medical centers worldwide, our faculty actively contributes to the development of personalized medicine and the future of oncogenomics.

CEO and CSO

Pier Paolo Pandolfi

MD, PhD, FRCP, CEO and CSO, PTEN Research Institute

Scientific Members

PTEN Research Institute brings together a global network of leading scientists dedicated to advancing the understanding of PTEN-related syndromes and cancer biology.

Assistant Members

Our Assistant Members contribute to ongoing research, clinical studies, and patient care in collaboration with the scientific leadership of the Institute.

  • Federica Centofanti, PhD, University of Tor Vergata, Rome, Italy
  • Fiorenza Mannino, MD, Cervello Hospital, Palermo
  • Antonino Pantaleo MD, Cervello Hospital, Palermo
  • Francesca Mercadante, MD, Cervello Hospital, Palermo
  • Maria Laura Centomo, PhD, MD Anderson Cancer Center, USA
  • Andrea Latini, PhD, University of Tor Vergata, Rome, Italy
  • Ludovico Graziani, MD, University of Tor Vergata, Rome, Italy
  • Barbara Rizzacasa, PhD, University of Tor Vergata, Rome, Italy